[Serum endorphins in the perinatal period]

Area of Science:

• Reproductive Endocrinology
• Neuroendocrinology
• Perinatal Medicine

Context:

• Radioimmunoassay techniques were employed to measure serum levels of beta-ELIR and N-terminal-beta-lipotropin.
• Measurements were taken in 22 pregnant women during late pregnancy, delivery, and the postpartum period (48 hours).
• The study aimed to approximate beta-endorphin concentration by analyzing the difference between beta-ELIR and N-terminal-beta-lipotropin levels.

Purpose:

• To investigate the dynamic changes in beta-endorphin serum levels throughout the final stages of pregnancy and delivery.
• To explore the potential of beta-endorphin as a biomarker for fetal distress.
• To correlate high beta-endorphin concentrations with specific pregnancy outcomes, such as the delivery of a dystrophic infant.

Summary:

• Beta-endorphin levels were significantly elevated during delivery compared to late pregnancy in 12 out of 22 women.
• Extremely high beta-endorphin concentrations were noted in three pregnant women who delivered dystrophic infants.
• These findings suggest a strong association between elevated beta-endorphin and fetal distress.

Impact:

• Highlights beta-endorphin as a potential non-invasive indicator for monitoring fetal well-being during labor.
• May lead to earlier detection and intervention for fetal distress, improving perinatal outcomes.
• Provides a basis for further research into the physiological mechanisms linking maternal beta-endorphin and fetal status.